ハロゲン化ピコリン酸誘導体/亜鉛(II)錯体のインスリン様作用

書誌事項

タイトル別名
  • Insulinomimetic activity of zinc (II) complexes with halogenated picolinic acids.
  • ハロゲンカ ピコリンサン ユウドウタイ アエン 2 サクタイ ノ インスリン ヨウ サヨウ

この論文をさがす

抄録

We prepared six new zinc(II) complexes of halogenated picolinic acids with a Zn(N2O2) coordination mode and evaluated for their insulinomimetic activities by in vitro study. By introducing an electron withdrawing halogen groups into the picolinic acid, we prepared bis(4- or 6-chloro picolinato), bis(4-, 5- or 6-iodo picolinato), and bis(6-bromo picolinato)/zinc(II) complexes (Zn(4cpa)2, Zn(6cpa)2, Zn(4ipa)2, Zn(5ipa)2, Zn(6ipa)2, and Zn(6bpa)2, respectively). By in vitro evaluation of the inhibition of free fatty acid (FFA) release from isolated rat adipocytes in the presence of epinephrine, the insulinomimetic activities of Zn(4cpa)2, Zn(6cpa)2, Zn(4ipa)2, Zn(6ipa)2, and Zn(6bpa)2 (IC50 = 0.64, 0.60, 0.77, 0.85, and 0.50 mM, respectvely) were found to be higher than that of bis(picolinato)/zinc(II) complex (Zn(pic)2) (IC50 = 1.00 mM) in terms of IC50 value, the 50% inhibition concentrations for the FFA release from rat adipocytes.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (6)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ